South & Central America Dry Eye Products Market Forecast to 2031

At 2.7% CAGR, South & Central America Dry Eye Products Market is Projected to be Worth US$ 316.84 Million by 2031, says The Research team

According to The Research team’ research, the South & Central America dry eye products market was valued at US$ 255.13 million in 2023 and is expected to reach US$ 316.84 million by 2031, registering a CAGR of 2.7% from 2023 to 2031. Ongoing research and growing pipeline for dry eye products and rising prevalence of dry eye are among the critical factors attributed to drive the South & Central America dry eye products market growth.

The dry eye condition is expected to be seen in the majority of the population across the world in the coming years. Many research studies have proven dry eye as a life-style disease. Improvements or changes in daily habits such as sleep, diet, and exercise are included in the treatment of dry eyes. Additionally, the stressful life among people across the world is likely to increase the incidences of dry eyes. Therefore, the rising incidences of dry eyes are expected to propel the demand for dry eye products in the coming years.

The advancement in technology has resulted in increased product development. Various companies are entering the market, which is contributing greatly to enhance market growth. Various companies have designed various innovative formulae to offer better eye drops for dry eye conditions. The cycle of product development is continuous and is likely to act as a vital growth factor during the forecast period. For instance, in 2019, Aldeyra Therapeutics had enrolled for the RENEW phase three clinical trial for its reproxalap ophthalmic solution (0.25%) to treat moderate to severe dry eye conditions. Similarly, Novaliq has two products in pipelines, such as NOVO3 (100% perfluorohexyloctane) and CyclASol (ophthalmic solution of 0.1% cyclosporine A in EyeSol).

Some companies are focusing on innovating other forms of products that can treat dry eye conditions. For instance, in October 2018, Oyster Point Pharma has a nasal spray which is in phase three clinical trial for the treatment of DED. The product is developed from the compound OC–01, which is highly selective nicotinic acetylcholine receptor (nAChR) agonist, which targets the parasympathetic nervous system and controls tear film homeostasis partially through the trigeminal nerve. The company is expected to submit a new drug application (NDA) in 2020. Thus, such innovations are likely to act as trending factors and are expected to contribute significantly to the market growth in the coming years.

On the contrary, side effects of eye drops and product recalls hamper the growth of South & Central America dry eye products market.

Based on product, the South & Central America dry eye products market is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held 48.1% market share in 2023, amassing US$ 122.67 million. It is projected to garner US$ 154.19 million by 2031 to register 2.9% CAGR during 2023–2031. Furthermore, the anti-inflammatory drugs segment is subcategorized into cyclosporine, corticosteroid, and others. Additionally, the punctal plugs segment is subsegmented into dissolvable and removable.

In terms of dosage form, the South & Central America dry eye products market is segmented into eye drops, gel, capsules and tablets, and others. The eye drops segment held 65.3% share South & Central America dry eye products market in 2023, amassing US$ 166.48 million. It is anticipated to garner US$ 209.81 million by 2031 to expand at 2.9% CAGR during 2023–2031.

By type, the South & Central America dry eye products market is bifurcated into OTC and prescription. The OTC segment held 58.4% share of South & Central America dry eye products market in 2023, amassing US$ 148.89 million. It is projected to garner US$ 189.49 million by 2031 to expand at 3.1% CAGR from 2023 to 2031.

Based on distribution channel, the South & Central America dry eye products market is categorized into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment held 46.0% share of South & Central America dry eye products market in 2023, amassing US$ 117.26 million. It is predicted to garner US$ 145.02 million by 2031 to expand at 2.7% CAGR between 2023 and 2031.

Based on country, the South & Central America dry eye products market is categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 58.7% share of South & Central America dry eye products market in 2023. It was assessed at US$ 149.69 million in 2023 and is likely to hit US$ 191.43 million by 2031, registering a CAGR of 3.1% during 2023–2031.

Key players operating in the South & Central America dry eye products market are Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Farmigea SpA, and Alcon AG, among others.

In September 2023, Bausch + Lomb Corporation (“Bausch + Lomb”), a subsidiary of Bausch Health Companies Inc completed its acquisition of XIIDRA (lifitegrast ophthalmic solution) 5%, a non- steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease focusing on inflammation associated with dry eye, and certain other ophthalmology assets.
In April 2021, MY OASIS is a cyber platform that allows eye care practitioners to grow their brand as a dry eye resource, broaden the reach of their practice, and provide access to solutions that can improve the quality of life for dry eye patients in their region. Its simple and intuitive design ensures a pleasant user experience.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America dry eye products market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America dry eye products market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America dry eye products market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Dry Eye Products Market – Key Market Dynamics
4.1 South & Central America Dry Eye Products Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Rising Prevalence of Dry Eye
4.2.2 Upsurge in Geriatric Population
4.3 Market Restraints
4.3.1 Side Effects of Eye Drops and Product Recalls
4.4 Market Opportunities
4.4.1 Increasing Initiatives for Eye Care Awareness
4.5 Future Trends
4.5.1 Ongoing Research and Growing Pipeline for Dry Eye Products
4.6 Impact of Drivers and Restraints:
5. Dry Eye Products Market – South & Central America Analysis
5.1 South & Central America Dry Eye Products Market Revenue (US$ Million), 2021–2031
6. South & Central America Dry Eye Products Market Analysis – by Product
6.1 Overview
6.2 Artificial Tears
6.2.1 Overview
6.2.2 Artificial Tears: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Anti-Inflammatory Drugs
6.3.1 Overview
6.3.2 Anti-Inflammatory Drugs: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.3.2.1 South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs
6.4 Punctal Plugs
6.4.1 Overview
6.4.2 Punctal Plugs: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.4.2.1 South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs
6.5 Secretagogues
6.5.1 Overview
6.5.2 Secretagogues: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.6 Oral Omega Supplements
6.6.1 Overview
6.6.2 Oral Omega Supplements: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7. South & Central America Dry Eye Products Market Analysis – by Dosage Form
7.1 Overview
7.2 Eye Drops
7.2.1 Overview
7.2.2 Eye Drops: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Gels
7.3.1 Overview
7.3.2 Gels: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Capsules and Tablets
7.4.1 Overview
7.4.2 Capsules and Tablets: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
8. South & Central America Dry Eye Products Market Analysis – by Type
8.1 Overview
8.2 OTC
8.2.1 Overview
8.2.2 OTC: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Prescription
8.3.1 Overview
8.3.2 Prescription: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
9. South & Central America Dry Eye Products Market Analysis – by Distribution Channel
9.1 Overview
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Online Pharmacies
9.4.1 Overview
9.4.2 Online Pharmacies: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10. South & Central America Dry Eye Products Market – Country Analysis
10.1 South and Central America
10.1.1 South and Central America: Dry Eye Products Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Brazil: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.3 Brazil: Dry Eye Products Market Breakdown, by Product
10.1.1.1.3.1 Brazil: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.1.3.2 Brazil: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.1.4 Brazil: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.1.5 Brazil: Dry Eye Products Market Breakdown, by Type
10.1.1.1.6 Brazil: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.2 Argentina: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.3 Argentina: Dry Eye Products Market Breakdown, by Product
10.1.1.2.3.1 Argentina: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.2.3.2 Argentina: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.2.4 Argentina: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.2.5 Argentina: Dry Eye Products Market Breakdown, by Type
10.1.1.2.6 Argentina: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.3 Rest of South and Central America: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South and Central America: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.3 Rest of South and Central America: Dry Eye Products Market Breakdown, by Product
10.1.1.3.3.1 Rest of South and Central America: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.3.3.2 Rest of South and Central America: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.3.4 Rest of South and Central America: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.3.5 Rest of South and Central America: Dry Eye Products Market Breakdown, by Type
10.1.1.3.6 Rest of South and Central America: Dry Eye Products Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Dry Eye Products Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Santen Pharmaceutical Co Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Johnson & Johnson
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 OASIS Medical
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 URSAPHARM Arzneimittel GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rohto Pharmaceutical Co Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 OCuSOFT Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bausch Health Companies Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 AbbVie Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Farmigea SpA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Alcon AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Research Team
13.2 Glossary of Terms

LIST OF TABLES

Table 1. South & Central America Dry Eye Products Market Segmentation
Table 2. South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs
Table 3. South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs
Table 4. Brazil: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 5. Brazil: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Anti-inflammatory Drugs
Table 6. Brazil: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Punctal Plugs
Table 7. Brazil: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Dosage Form
Table 8. Brazil: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 9. Brazil: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 10. Argentina: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 11. Argentina: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Anti-inflammatory Drugs
Table 12. Argentina: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Punctal Plugs
Table 13. Argentina: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Dosage Form
Table 14. Argentina: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 15. Argentina: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 16. Rest of South and Central America: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 17. Rest of South and Central America: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Anti-inflammatory Drugs
Table 18. Rest of South and Central America: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Punctal Plugs
Table 19. Rest of South and Central America: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Dosage Form
Table 20. Rest of South and Central America: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 21. Rest of South and Central America: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 22. Recent Organic Growth Strategies in the Dry Eye Products Market
Table 23. Recent Inorganic Growth Strategies in the Dry Eye Products Market
Table 24. Glossary of Terms

LIST OF FIGURES

Figure 1. South & Central America Dry Eye Products Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. South & Central America Dry Eye Products Market Revenue (US$ Million), 2021–2031
Figure 4. Dry Eye Products Market Share (%) – by Product (2023 and 2031)
Figure 5. Artificial Tears: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 6. Anti-Inflammatory Drugs: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Punctal Plugs: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Secretagogues: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Oral Omega Supplements: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Others: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. South & Central America Dry Eye Products Market Share (%) – by Dosage Form (2023 and 2031)
Figure 12. Eye Drops: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Gels: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Capsules and Tablets: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. South & Central America Dry Eye Products Market Share (%) – by Type (2023 and 2031)
Figure 17. OTC: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Prescription: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Dry Eye Products Market Share (%) – by Distribution Channel (2023 and 2031)
Figure 20. Retail Pharmacies: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Hospital Pharmacies: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Online Pharmacies: South & Central America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. South and Central America: Dry Eye Products Market, by Key Country – Revenue (2023) (US$ Million)
Figure 24. South and Central America: Dry Eye Products Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 25. Brazil: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million)
Figure 26. Argentina: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million)
Figure 27. Rest of South and Central America: Dry Eye Products Market – Revenue and Forecast to 2031(US$ Million)
Figure 28. Growth Strategies in the Dry Eye Products Market